Innovations in Algal Drug Research, with a Focus On Diabetes Mellitus (DM) Inhibitors of Enzymes

Abstract

The growing incidence of diabetes mellitus (DM) and its related health problems present a serious problem for healthcare systems across the world. One potential strategy for treating DM is the use of enzyme inhibitors to control glucose metabolism. This abstract highlight recent advances in the exploration of chemicals generated from algae as possible inhibitors of DM enzymes. As a renewable resource with a high concentration of bioactive chemicals, algae provide significant benefits to the search for new pharmaceuticals. In this article, we examine the many different types of algae and bioactive substances that have demonstrated inhibitory potential against DM-related enzymes. We review the pharmacological characteristics, preclinical data, and mechanisms of action for compounds produced from algae that show promise as DM enzyme inhibitors. In addition, we stress the importance of conducting thorough clinical trials to verify their safety and effectiveness in human beings. The combination of cutting-edge drug discovery methods with algae biotechnology shows great promise for the creation of novel medicines for the treatment of diabetes mellitus (DM), which might one day provide a long-term answer to this urgent global health problem.